Aptus Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	465.75	245.58	178.57	138.97	105.07
Revenue Growth (YoY)	89.65%	37.52%	28.49%	32.27%	106.18%
Cost of Revenue	213.7	90.37	68.26	47.63	38.31
Gross Profit	252.05	155.21	110.31	91.35	66.76
Selling, General & Admin	52.05	63.56	43.21	30.37	26.39
Other Operating Expenses	125.52	43.16	51.2	54.41	37.05
Operating Expenses	181.66	109.37	96.53	86.58	64.39
Operating Income	70.39	45.84	13.78	4.76	2.37
Interest Expense	-7.98	-2.98	-1.6	-0.99	-0.84
Interest & Investment Income	-	0.77	0.25	-	-
Other Non Operating Income (Expenses)	1.34	-1.68	-0.79	-0.44	-0.07
EBT Excluding Unusual Items	63.75	41.95	11.64	3.33	1.46
Pretax Income	63.75	41.95	11.64	3.33	1.46
Income Tax Expense	17.55	10.96	3.04	0.9	0.45
Net Income	46.2	31	8.6	2.43	1.01
Net Income to Common	46.2	31	8.6	2.43	1.01
Net Income Growth	49.05%	260.45%	254.23%	140.83%	163.41%
Shares Outstanding (Basic)	6	5	2	1	1
Shares Outstanding (Diluted)	6	5	2	1	1
Shares Change (YoY)	22.09%	224.21%	105.42%	-0.02%	16.87%
EPS (Basic)	7.78	6.37	5.73	3.32	1.38
EPS (Diluted)	7.78	6.37	5.73	3.32	1.38
EPS Growth	22.13%	11.13%	72.44%	140.87%	125.39%
Free Cash Flow	-90.46	-24.6	-25.04	-5.34	-
Free Cash Flow Per Share	-15.23	-5.06	-16.69	-7.31	-
Gross Margin	54.12%	63.20%	61.77%	65.73%	63.54%
Operating Margin	15.11%	18.67%	7.72%	3.43%	2.26%
Profit Margin	9.92%	12.62%	4.82%	1.75%	0.96%
Free Cash Flow Margin	-19.42%	-10.02%	-14.02%	-3.84%	-
EBITDA	74.47	48.49	15.92	6.57	2.8
EBITDA Margin	15.99%	19.75%	8.92%	4.73%	2.67%
D&A For EBITDA	4.08	2.65	2.15	1.81	0.43
EBIT	70.39	45.84	13.78	4.76	2.37
EBIT Margin	15.11%	18.67%	7.72%	3.43%	2.26%
Effective Tax Rate	27.53%	26.11%	26.10%	27.10%	31.06%
Revenue as Reported	467.08	246.36	178.82	138.97	105.07
Advertising Expenses	-	27.36	20.61	15.24	17.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.